Intelicare(ASX) ICR

Market CapA$18.60M

Since IPO (2020)-91%

5 Year-82%

1 Year+100%

1 Month+24%

A$0.03

+4.00%

+0.00Today

Intelicare last closing stock price
Metric	Price	Date
Last close	AUD 0.03	2026-08-13

Intelicare stock price return by period
Period	Price return	Price at period start	Period start date
1 week	+18.18%	AUD 0.02	2026-08-06
1 month	+23.81%	AUD 0.02	2026-07-13
3 month	+0%	AUD 0.03	2026-05-15
Year to date	+8.33%	AUD 0.02	2025-12-31
1 year	+100%	AUD 0.01	2025-08-13
3 year	+116.67%	AUD 0.01	2023-08-14
5 year	-82.07%	AUD 0.15	2021-08-13
Since inception	-90.54%	AUD 0.27	2020-05-25

Intelicare Financials at a Glance

Market Cap

A$18.60M

Revenue (TTM)

A$1.60M

Net Income (TTM)

-A$5.21M

EPS (TTM)

-A$0.01

P/E Ratio

-4.81

Dividend

A$0.00

Beta (Volatility)

0.09 (Low)

Dividend

A$0.00

Beta (Volatility)

0.09 (Low)

Price

A$0.03

Volume

Open

A$0.02

Price

A$0.03

Volume

Open

A$0.02

Previous Close

A$0.03

Daily Range

A$0.02 - A$0.03

52-Week Range

A$0.01 - A$0.04

Estimated Earnings Date

Sep 2, 2026

Dividend

A$0.00

Beta (Volatility)

0.09 (Low)

Price

A$0.03

Volume

Open

A$0.02

Previous Close

A$0.03

Daily Range

A$0.02 - A$0.03

52-Week Range

A$0.01 - A$0.04

Estimated Earnings Date

Sep 2, 2026

ICR News

No articles available.

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Intelicare

Intelicare Holdings Limited is an innovative company based in Leederville, Australia, focused on providing predictive analytics solutions for the aged care and health industries. Founded in 2016, the company combines hardware and software to enhance the quality of care for seniors and individuals with disabilities.

Products and Services

InteliLiving: A solution designed to assist seniors and individuals with disabilities
Specialized monitoring systems for elderly and vulnerable populations
Comprehensive analytics tools for aged care facilities

Growth Outlook

Recent revenue growth indicates increasing demand for healthcare analytics
Expansion plans targeting new markets within Australia and beyond
Investment in R&D to enhance product offerings and capabilities

Financial Highlights

Latest quarterly revenue of AUD 489,707, showing a positive trend
Trailing twelve months (TTM) net income margin of -8.06%, indicating potential for improvement
Current ratio of 0.85 suggests adequate short-term financial health

Intelicare Holdings Limited operates in a niche market with significant growth potential, particularly as the demand for aged care solutions continues to rise. The company's focus on innovative technology positions it well to capitalize on emerging trends in healthcare analytics. Recent financial data reflects a commitment to growth, with increasing revenues and strategic investments aimed at enhancing product offerings. The company's ability to adapt and innovate in a rapidly evolving industry may attract interest from potential investors looking for opportunities in the healthcare sector.

AI Generated • Jul 19, 2026

Industry

Health Care Technology

Sector

Health Care

Headquarters

Leederville, WA 6007, AU

ICR Financials

Key Financial Metrics (TTM)

Gross Margin

-637.73%

Operating Margin

-1108.70%

Net Income Margin

-806.06%

Return on Equity

-578.72%

Return on Capital

N/A

Return on Assets

-148.95%

Earnings Yield

-20.79%

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

A$18.60M

Shares Outstanding

715.31M

Volume

Avg. Volume

281.76K

Financials (TTM)

Gross Profit

-A$2.66M

Operating Income

-A$5.55M

EBITDA

-A$4.83M

Operating Cash Flow

-A$4.39M

Capital Expenditure

-A$9.55K

Free Cash Flow

-A$4.40M

Cash & ST Invst.

A$1.05M

Total Debt

A$1.09M

Intelicare Performance Analysis

Intelicare sequential (quarter-over-quarter) revenue growth by fiscal quarter
Fiscal quarter	Period end	QoQ growth
Q4	2024-06-30	28.5%
Q2	2024-12-31	217.8%
Q4	2025-06-30	-9.0%
Q2	2025-12-31	7.5%

Intelicare sequential (quarter-over-quarter) diluted earnings per share growth by fiscal quarter
Fiscal quarter	Period end	QoQ growth
Q4	2024-06-30	-125.8%
Q2	2024-12-31	51.4%
Q4	2025-06-30	11.8%
Q2	2025-12-31	20.0%

Revenue Growth Rate

Annual and quarterly growth comparison

Currently no data to display.

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Currently no data to display.

Quarterly Performance

Name

Q2 2026YOY CHG

Revenue

A$489.71K

+299.2%

Gross Profit

-A$644.02K

+25.5%

Gross Margin

-1.32%

N/A

Market Cap

A$18.60M

N/A

Market Cap/Employee

A$2.32M

N/A

Employees

N/A

Net Income

-A$1.37M

-106.6%

EBITDA

-A$1.23M

+17.8%

Quarterly Fundamentals

Name

Q2 2026YOY CHG

Total Cash

A$1.05M

-25.6%

Total Debt

A$1.09M

+256.3%

Accounts Receivable

A$188.58K

+136.9%

Inventory

A$209.54K

-24.6%

Long Term Debt

A$17.83K

N/A

Short Term Debt

A$1.07M

+250.5%

Return on Assets

-1.49%

N/A

Return on Invested Capital

18.46%

N/A

Free Cash Flow

-A$1.54M

-226.9%

Operating Cash Flow

-A$1.54M

-226.3%

Other Investments to Explore

People Also Watch

SymbolSymbol / CompanyCompanyPricePrice Chg

VBS.AXVectus Biosystems Limited

VBS.AXVectus Biosystems LimitedA$0.16+0.00%

IXC.AXInvex Therapeutics Ltd

IXC.AXInvex Therapeutics LtdA$0.12+0.00%

BGT.AXBio-Gene Technology Limited

BGT.AXBio-Gene Technology LimitedA$0.02+0.00%

HIQ.AXHITIQ Limited

HIQ.AXHITIQ LimitedA$0.01+0.00%

PER.AXPercheron Therapeutics Limited

PER.AXPercheron Therapeutics LimitedA$0.01+11.11%

IVX.AXInvion Limited

IVX.AXInvion LimitedA$0.04+2.56%

GLH.AXGlobal Health Limited

GLH.AXGlobal Health LimitedA$0.06-7.69%

Trending Stocks

SymbolSymbol / CompanyCompanyPricePrice Chg

ONDSOndas

ONDSOndas$8.91-0.09%

SMCISuper Micro Computer

SMCISuper Micro Computer$39.16+0.04%

SPCXSpace Exploration Technologies

SPCXSpace Exploration Technologies$141.29-0.03%

TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x ETF

TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x ETF$8.64+0.07%

INTCIntel

INTCIntel$104.56+0.04%

NOKNokia

NOKNokia$10.56+0.02%

PATHUiPath

PATHUiPath$16.68+0.09%

Questions About ICR

What is the current price of Intelicare?

Intelicare is trading at A$0.03 per share.

What is the 52-week range for Intelicare?

Over the past 52 weeks, Intelicare has traded between A$0.01 and A$0.04.

How much debt does Intelicare have?

Intelicare total debt is unavailable.

How much cash does Intelicare have on hand?

Intelicare does not have cash on hand data available.

What is Intelicare’s dividend yield?

Intelicare does not currently have a dividend yield.

Intelicare(ASX) ICR

Intelicare Financials at a Glance

ICR News

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

About Intelicare

ICR Financials

Key Financial Metrics (TTM)

Stock Overview

Financials (TTM)

Intelicare Performance Analysis

Revenue Growth Rate

Earnings Per Share Growth Rate

Quarterly Performance

Quarterly Fundamentals

Other Investments to Explore

People Also Watch

Trending Stocks

Questions About ICR

What is the current price of Intelicare?

What is the 52-week range for Intelicare?

How much debt does Intelicare have?

How much cash does Intelicare have on hand?

What is Intelicare’s dividend yield?

Premium Investing Services